Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Research Center, |
RCV000005342 | SCV000746318 | pathogenic | Glucocorticoid deficiency with achalasia | 2017-12-03 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000005342 | SCV002019976 | pathogenic | Glucocorticoid deficiency with achalasia | 2020-08-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV002288466 | SCV002578572 | likely pathogenic | not provided | 2022-04-01 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 29255950, 11062474) |
Labcorp Genetics |
RCV002288466 | SCV004294188 | pathogenic | not provided | 2023-11-06 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg312*) in the AAAS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in AAAS are known to be pathogenic (PMID: 11159947). This variant is present in population databases (rs121918547, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with achalasia-addisonianism-alacrimia syndrome (PMID: 11062474, 29255950). ClinVar contains an entry for this variant (Variation ID: 5039). For these reasons, this variant has been classified as Pathogenic. |
OMIM | RCV000005342 | SCV000025520 | pathogenic | Glucocorticoid deficiency with achalasia | 2000-11-01 | no assertion criteria provided | literature only |